Targeted Therapies
Dr. Andre Goy, from John Theurer Cancer Center, on Crizotinib for Pediatric Patients With ALCL
Conferences > 2012 ASCO Annual Meeting
Targeting the ALK gene with the oral agent crizotinib slowed or eliminated signs of tumor growth in pediatric patients with aggressive forms of neuroblastoma, ALCL, and IMTs.
Conferences > 2012 ASCO Annual Meeting
Located in Tampa, Florida, Moffitt Cancer Center enjoys a reputation as one of the world’s most sophisticated cancer centers.
Oncology & Biotech News > Academy
An interview with Brian Rini, MD, whose research has focused on RCC, prostate, and other genitourinary cancers, as well as on antiangiogenic therapy and immunotherapy.
Oncology Live > Profiles in Research
Researchers have determined that breast cancer can be classified into 10 different subtypes instead of four subtypes as previously thought.
Leonard M. Neckers, PhD, has been studying the role of the molecular chaperone Hsp90 in signal transduction and the translational development of Hsp90-targeted anticancer agents for two decades.
Oncology Live > Pathways
Hsp90 may be referred to as the 'guardian of the proteome,' since it regulates the correct structure and function of many of the important proteins encoded by our DNA.
Oncology Live > Pathways
Before the oncology treatment paradigm can move from a one-size-fits-all model to true personalized medicine, the medical establishment must find a cost-effective way to identify biomarkers.
Oncology & Biotech News > News
The USC Norris Comprehensive Cancer Center and Hospital has long enjoyed a national reputation as a leading resource for cancer research, treatment, prevention, and education.
Oncology & Biotech News > Academy
The keynote address at the ASCO Genitourinary Cancers Symposium highlighted a collaborative effort to develop a comprehensive molecular classification of prostate cancer.
Oncology & Biotech News > Conference Highlights
Optical biomarkers derived from nondysplastic metaplastic cells can detect the presence of high-grade dysplasia and adenocarcinoma from Barrett's esophagus.
Oncology Live > Clinical Insights
This issue of Contemporary Oncology includes a focus on 2 challenging situations: management of metastatic TNBC and of advanced stage NSCLC.
Contemporary Oncology > From the Editor
The use of advanced gene analysis techniques
in a small group of women with triple-negative
metastatic breast cancer has revealed
activity in two pathways found in most patients with this subtype.
Oncology Live > Specialty Focus
As research progresses, optimal treatment of breast cancer will involve individualization of therapy to focus on specific targets driving each patient's cancer.
Oncology & Biotech News > Conference Highlights
HER2 status in patients with breast cancer has emerged as a durable and effective marker for evaluating tumors and selecting therapies.
Oncology Live > Features
The MET signaling network has emerged as an important target for cancer therapy, with a particularly significant role in controlling the cancer hallmarks of metastasis and angiogenesis.
Oncology Live > Pathways
The Massachusetts General Hospital (MGH) Cancer Center comprises 23 fully integrated, multidisciplinary clinical programs, as well as an extensive array of support and educational services.
Oncology & Biotech News > Academy
Jill M. Siegfried, PhD, is an investigator into the role of growth factors and hormones in the development and growth of lung cancer.
Oncology Live > Pathways
It is always difficult to distinguish what may legitimately be considered disease flare from the more likely scenario of the events simply representing the natural history of the malignancy.
Oncology Live > From the Editor
An interview with Mark G. Kris, MD, chief of the Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center, who has dedicated the past 30 years to helping patients with lung cancer.
Oncology Live > Profiles in Research
External Resources
American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747
Copyright HCPLive 2006-2012
Intellisphere, LLC. All Rights Reserved.
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747
Copyright HCPLive 2006-2012
Intellisphere, LLC. All Rights Reserved.